Neuroradiology Division, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA Correspondence to Dr R G González, Neuroradiology Division, Massachusetts General Hospital, ...

Background Direct aspiration thrombectomy is a well-established method for mechanical thrombectomy in acute ischemic stroke. Yet, the influence of aspiration catheter internal diameter (ID) on ...

Correspondence to Dr Jeremy J Heit, Department of Radiology, Neuroimaging and Neurointervention, Stanford University Hospital, 300 Pasteur Drive, S0047 Stanford, CA 94305, USA; jheit{at}stanford.edu ...

Introduction Mechanical thrombectomy (MT) is increasingly used for large-vessel occlusions (LVO), but randomized clinical trial (RCT) level data with regard to differences in clinical outcomes of MT ...

Background Due to its high efficacy, flow diversion is increasingly used in the management of unruptured and recanalized aneurysms. Because of the need for perioperative dual antiplatelet treatment ...

Correspondence to Dr Fatih Seker, Department of Neuroradiology, Heidelberg University Hospital, Im Neuenheimer Feld 400, Heidelberg 69120, Germany; fatih.seker{at}med.uni-heidelberg.de Purpose ...

Background Intracranial atherosclerotic disease (ICAD) significantly contributes to ischemic stroke, especially among Asian populations. Large vessel occlusion (LVO) due to underlying ICAD accounts ...

Correspondence to Dr Santiago Ortega-Gutierrez, Division of Neurointerventional Surgery-Interventional Neuroradiology, The University of Iowa Hospitals and Clinics, Iowa City, IA 52242, USA; ...

Correction: Correspondence on 'Safety and efficacy of the Contour Neurovascular System for treating intracranial aneurysms: a systematic review and meta-analysis' by Günkan et al ...

Cerebrovascular and Endovascular Division, Department of Neurosurgery, Tufts Medical Center, and Tufts University School of Medicine, Boston, Massachusetts, USA Correspondence to Dr A M Malek, ...

Introduction Inflammation plays an important role in mediating morbidity following subarachnoid hemorrhage (SAH), including the development of cerebral vasospasm and hospital-acquired infections.

Background Malignant gliomas continue to have a poor clinical outcome with available therapies. In the past few years, new targeted biologic therapies have been studied, with promising results.